Telehealth & Digital Health

Daré Bioscience launches telehealth for DARE to PLAY™, the first evidence-backed topical sildenafil cream designed to address female sexual arousal.

A new walk-in lab with pediatric care opens in The Marketplace at Steamtown, marking a strategic move in retail health and enhancing local convenience.

Pharma veteran Pinder Sahota joins digital health firm Reset Health, signaling a strategic shift to integrated care in the new era of weight-loss drugs.

Zelluna partners with Medpace for a first-in-human trial of its ZIMA-101 TCR-NK therapy, a new 'off-the-shelf' approach for hard-to-treat solid tumors.

A new book offers a critical roadmap for medical device developers facing a storm of new AI regulations, complex FDA rules, and evolving IP law.

Bolstered by a top regulatory expert and unique veterinary data, Vivos Inc. is set to file for human trials of its precision injectable cancer treatment.

A new webinar explores how integrating data into EHRs is overcoming major barriers to improve mental health outcomes. Learn how this tech revolutionizes care.

With a fresh $118M in funding, Garner Health's AI platform aims to cut healthcare costs by guiding millions of patients to top-rated doctors.

Enanta Pharmaceuticals unveils promising data for EDP-978, an oral drug targeting the root cause of conditions like chronic hives, asthma, and eczema.

A national report card gives the U.S. a 'B' on rare disease policy, but stark state-by-state disparities leave millions vulnerable to financial ruin.

A new company aims to solve why patients stop neurological treatments, focusing on the critical, unsupported time between doctor appointments.

A new 'zero-disruption' plate from TheWell Bioscience aims to solve key challenges in organoid research, promising more reliable data for drug discovery.

Amid market volatility, Lavior is boosting US production and launching dual product lines, a strategic move to ensure stability for clinics and consumers alike.

As Omada Health preps its 2025 results, all eyes are on whether its blend of tech, human coaching, and GLP-1 support can deliver sustainable profits.

Bionano's 2026 virtual event will showcase how Optical Genome Mapping is revolutionizing cancer and genetic disease research and paving a path to clinical use.

Backed by a proven billion-dollar impact model, 14 new startups are using AI, neuroscience, and philanthropy to revolutionize mental healthcare.

A Chinese biotech's novel nasal spray flu vaccine enters trials. Its unique design could finally make it safe for the elderly and expand global access.

Beverly Hills Plastic Surgery® is moving beyond aesthetics with its "Eternal G.L.O.W." series, a year-long program focused on holistic health.

Guardforce AI aims to acquire a leading speech therapy platform, signaling a major strategic pivot from secured logistics to the booming AI healthcare market.

From its unique seat at the World Government Summit, CanSinoBIO unveils its next-gen vaccine pipeline and global strategy to fight humanity's oldest diseases.